VCNX Annual CFO
-$17.23 M
+$1.84 M+9.65%
31 December 2023
Summary:
As of January 23, 2025, VCNX annual cash flow from operations is -$17.23 million, with the most recent change of +$1.84 million (+9.65%) on December 31, 2023. During the last 3 years, it has risen by +$11.41 million (+39.84%). VCNX annual CFO is now at all-time high.VCNX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCNX Quarterly CFO
-$3.21 M
+$1.21 M+27.36%
30 September 2024
Summary:
As of January 23, 2025, VCNX quarterly cash flow from operations is -$3.21 million, with the most recent change of +$1.21 million (+27.36%) on September 30, 2024. Over the past year, it has increased by +$1.43 million (+30.76%). VCNX quarterly CFO is now -3.62% below its all-time high of -$3.10 million, reached on September 30, 2023.VCNX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCNX TTM CFO
-$15.85 M
-$112.00 K-0.71%
30 September 2024
Summary:
As of January 23, 2025, VCNX TTM cash flow from operations is -$15.85 million, with the most recent change of -$112.00 thousand (-0.71%) on September 30, 2024. Over the past year, it has increased by +$980.00 thousand (+5.82%). VCNX TTM CFO is now -241.95% below its all-time high of -$4.63 million, reached on March 31, 2017.VCNX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCNX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.7% | +30.8% | +5.8% |
| 3 y3 years | +39.8% | +36.4% | +17.1% |
| 5 y5 years | +31.8% | +36.4% | +17.1% |
VCNX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.9% | -3.6% | +41.8% | -0.7% | +37.4% |
| 5 y | 5-year | at high | +43.9% | -3.6% | +65.5% | -0.7% | +48.4% |
| alltime | all time | at high | +43.9% | -3.6% | +69.4% | -241.9% | +51.2% |
Vaccinex Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.21 M(-27.4%) | -$15.85 M(+0.7%) |
| June 2024 | - | -$4.42 M(-4.7%) | -$15.73 M(-6.5%) |
| Mar 2024 | - | -$4.63 M(+29.0%) | -$16.83 M(-2.4%) |
| Dec 2023 | -$17.23 M(-9.6%) | -$3.59 M(+16.1%) | -$17.23 M(-5.5%) |
| Sept 2023 | - | -$3.10 M(-43.8%) | -$18.24 M(-5.4%) |
| June 2023 | - | -$5.51 M(+9.3%) | -$19.29 M(+0.9%) |
| Mar 2023 | - | -$5.04 M(+9.6%) | -$19.12 M(+0.2%) |
| Dec 2022 | -$19.07 M(-24.6%) | -$4.60 M(+10.9%) | -$19.07 M(-2.8%) |
| Sept 2022 | - | -$4.15 M(-22.3%) | -$19.62 M(-8.9%) |
| June 2022 | - | -$5.33 M(+6.7%) | -$21.53 M(-7.1%) |
| Mar 2022 | - | -$5.00 M(-2.9%) | -$23.18 M(-8.4%) |
| Dec 2021 | -$25.30 M(-11.7%) | -$5.14 M(-15.1%) | -$25.30 M(-4.7%) |
| Sept 2021 | - | -$6.06 M(-13.2%) | -$26.54 M(-10.9%) |
| June 2021 | - | -$6.98 M(-1.9%) | -$29.79 M(+5.4%) |
| Mar 2021 | - | -$7.11 M(+11.5%) | -$28.25 M(-1.4%) |
| Dec 2020 | -$28.65 M | -$6.38 M(-31.4%) | -$28.65 M(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$9.31 M(+70.8%) | -$28.07 M(-4.0%) |
| June 2020 | - | -$5.45 M(-27.5%) | -$29.25 M(-1.7%) |
| Mar 2020 | - | -$7.51 M(+29.4%) | -$29.75 M(-3.1%) |
| Dec 2019 | -$30.71 M(+21.5%) | -$5.80 M(-44.7%) | -$30.71 M(-5.4%) |
| Sept 2019 | - | -$10.49 M(+76.4%) | -$32.47 M(+11.2%) |
| June 2019 | - | -$5.95 M(-29.8%) | -$29.20 M(+2.1%) |
| Mar 2019 | - | -$8.48 M(+12.2%) | -$28.59 M(+13.1%) |
| Dec 2018 | -$25.28 M(+18.2%) | -$7.56 M(+4.7%) | -$25.28 M(+5.5%) |
| Sept 2018 | - | -$7.22 M(+35.4%) | -$23.97 M(+11.6%) |
| June 2018 | - | -$5.33 M(+3.3%) | -$21.48 M(-2.0%) |
| Mar 2018 | - | -$5.17 M(-17.3%) | -$21.92 M(+2.5%) |
| Dec 2017 | -$21.39 M(+8.5%) | -$6.25 M(+32.0%) | -$21.39 M(+41.3%) |
| Sept 2017 | - | -$4.73 M(-18.0%) | -$15.14 M(+45.5%) |
| June 2017 | - | -$5.77 M(+24.6%) | -$10.41 M(+124.6%) |
| Mar 2017 | - | -$4.63 M | -$4.63 M |
| Dec 2016 | -$19.72 M | - | - |
FAQ
- What is Vaccinex annual cash flow from operations?
- What is the all time high annual CFO for Vaccinex?
- What is Vaccinex annual CFO year-on-year change?
- What is Vaccinex quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vaccinex?
- What is Vaccinex quarterly CFO year-on-year change?
- What is Vaccinex TTM cash flow from operations?
- What is the all time high TTM CFO for Vaccinex?
- What is Vaccinex TTM CFO year-on-year change?
What is Vaccinex annual cash flow from operations?
The current annual CFO of VCNX is -$17.23 M
What is the all time high annual CFO for Vaccinex?
Vaccinex all-time high annual cash flow from operations is -$17.23 M
What is Vaccinex annual CFO year-on-year change?
Over the past year, VCNX annual cash flow from operations has changed by +$1.84 M (+9.65%)
What is Vaccinex quarterly cash flow from operations?
The current quarterly CFO of VCNX is -$3.21 M
What is the all time high quarterly CFO for Vaccinex?
Vaccinex all-time high quarterly cash flow from operations is -$3.10 M
What is Vaccinex quarterly CFO year-on-year change?
Over the past year, VCNX quarterly cash flow from operations has changed by +$1.43 M (+30.76%)
What is Vaccinex TTM cash flow from operations?
The current TTM CFO of VCNX is -$15.85 M
What is the all time high TTM CFO for Vaccinex?
Vaccinex all-time high TTM cash flow from operations is -$4.63 M
What is Vaccinex TTM CFO year-on-year change?
Over the past year, VCNX TTM cash flow from operations has changed by +$980.00 K (+5.82%)